EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of Plerixafor Use at Different Peripheral Blood CD34+ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma

Eshana E Shah, Rebecca P Young, Sandy W Wong, Lloyd E Damon, Jeffrey L Wolf, Nina D Shah, Andrew D Leavitt, Paula Loeffler, Thomas G Martin

Biology of Blood and Marrow Transplantation · 2020-05 · 26 (5) · 876-883

DOI: 10.1016/j.bbmt.2019.11.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of Blood and Marrow Transplantation, 2020-05. Verfasst von Eshana E Shah und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington; Seattle Cancer Care Alliance, Seattle, Washingto…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Heterocyclic Compounds, Multiple Myeloma. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GlaxoSmithKline Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationHeterocyclic CompoundsMultiple MyelomaBenzylaminesCyclamsHematopoietic Stem Cell MobilizationHumansTransplantation, Autologous

Stichwörter der Autor:innen

Autologous stem cell collectionMobilizationMozobilMultiple myelomaPlerixafor

Substanzen

BenzylaminesCyclamsHeterocyclic Compoundsplerixafor

Autor:innen und Institutionen

  • Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington; Seattle Cancer Care Alliance, Seattle, Washington.
  • Department of Clinical Pharmacy, University of California, San Francisco, California.
  • Department of Medicine, Division of Hematology/Oncology/Blood and Marrow Transplant, University of California, San Francisco, California.
  • Department of Medicine, Division of Hematology/Oncology/Blood and Marrow Transplant, University of California, San Francisco, California; Department of Laboratory Medicine, University of California, San Francisco, Calif…
  • Department of Nursing, UCSF Health, University of California, San Francisco, California.
  • Department of Medicine, Division of Hematology/Oncology/Blood and Marrow Transplant, University of California, San Francisco, California. Electronic address: Tom.Martin@ucsf.edu.

Förderung

  • GlaxoSmithKline Australia

Zitieren

APA

Shah, E. E., Young, R. P., Wong, S. W., Damon, L. E., Wolf, J. L., Shah, N. D., Leavitt, A. D., Loeffler, P., & Martin, T. G. (2020). Impact of Plerixafor Use at Different Peripheral Blood CD34+ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation, 26(5), 876-883. https://doi.org/10.1016/j.bbmt.2019.11.024

Vancouver

Shah EE, Young RP, Wong SW, Damon LE, Wolf JL, Shah ND, et al. Impact of Plerixafor Use at Different Peripheral Blood CD34+ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation. 2020;26(5):876-883. doi:10.1016/j.bbmt.2019.11.024

BibTeX
@article{Shah2020,
  author = {Shah, Eshana E and Young, Rebecca P and Wong, Sandy W and Damon, Lloyd E and Wolf, Jeffrey L and Shah, Nina D and Leavitt, Andrew D and Loeffler, Paula and Martin, Thomas G},
  title = {Impact of Plerixafor Use at Different Peripheral Blood CD34+ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma},
  journal = {Biology of Blood and Marrow Transplantation},
  year = {2020},
  volume = {26},
  number = {5},
  pages = {876--883},
  doi = {10.1016/j.bbmt.2019.11.024}
}
Kostenlos starten →